Literature DB >> 24845683

A practical guide to subtotal nephrectomy in the rat with subsequent methodology for assessing renal and cardiac function.

Yuan Zhang1, Andrew R Kompa.   

Abstract

BACKGROUND: Chronic kidney disease (CKD), and its associated cardiovascular events, is one of the major causes of morbidity and recurrent hospitalization in Asian Pacific region. The subtotal nephrectomy (STNx) model has remained the state-of-the-art prototype which closely mimics human CKD and cardiac-renal syndrome. AIM AND METHODS: In this article, we comprehensively outline the procedure and methodology required to develop the rat model 5/6 nephrectomy and the associated procedures involved in assessing cardiac and renal functional outcomes. RESULTS AND
CONCLUSION: In addition, the expected functional outcomes from our own experience, and those of others, have been described. The STNx model in the rat is an established model of CKD and displays all the functional and structural hallmarks observed in the human condition. Lesser known are the cardiac effects of this model which make it ideal for studying cardiorenal syndrome.
© 2014 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; renal function and heart function; subtotal nephrectomy

Mesh:

Year:  2014        PMID: 24845683     DOI: 10.1111/nep.12279

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

Review 1.  Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Authors:  Omid Sadeghi-Alavijeh; Mohammad Tadayyon; Ben Caplin
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

Review 2.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

3.  Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction.

Authors:  Antoinette Bugyei-Twum; Armin Abadeh; Kerri Thai; Yanling Zhang; Melissa Mitchell; Golam Kabir; Kim A Connelly
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 4.  Profiling novel pharmacology of receptor complexes using Receptor-HIT.

Authors:  Elizabeth K M Johnstone; Kevin D G Pfleger
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

5.  Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.

Authors:  Yi Chang; Ying Ben; Hui Li; Yunzhao Xiong; Gege Chen; Juan Hao; Xuelian Ma; Xiaomeng Gao; Panpan Qiang; Tatsuo Shimosawa; Xiangting Wang; Fan Yang; Qingyou Xu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-09-17       Impact factor: 4.109

6.  Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis.

Authors:  Hassan Askari; Behjat Seifi; Mehri Kadkhodaee; Nima Sanadgol; Mohammed Elshiekh; Mina Ranjbaran; Parisa Ahghari
Journal:  EXCLI J       Date:  2018-01-02       Impact factor: 4.068

7.  Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension.

Authors:  Kazuhisa Sugai; Tomoyoshi Tamura; Motoaki Sano; Shizuka Uemura; Masahiko Fujisawa; Yoshinori Katsumata; Jin Endo; Joe Yoshizawa; Koichiro Homma; Masaru Suzuki; Eiji Kobayashi; Junichi Sasaki; Yoji Hakamata
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.